Drugs in clinical development for multiple sclerosis: focusing on anti-CD20 antibodies. Gasperini C, Haggiag S, Ruggieri S Expert Opin Investig Drugs. 2013 Jul 16. PMID: 23855792. Abstract CommentRecommendBookmarkWatch